Episodit
-
Case #2: A 60-Year-Old Type 2 Diabetic Woman with MASH and F3 Liver Fibrosis This Ace the Case activity will review a detailed case discussion on the latest clinical care guidelines and emerging treatments for MASH. Participants will explore novel treatment targets and the most recent clinical data for treating patients with MASH and cardiometabolic comorbidities. Gain practical insights for individualizing patient care plans in your practice. Don’t miss this opportunity to enhance your expertise and improve patient outcomes
-
Case #1: A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound During this Ace the Case activity, you will learn about risk factors for metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction–associated steatohepatitis (MASH), and advanced fibrosis, as well as the current and emerging noninvasive liver assessment tests.
-
Puuttuva jakso?
-
This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls. In this podcast, experts will discuss the following case: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention
-
This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls. In this podcast, experts will discuss the following case: A 62-Year-Old Diabetic Woman with an LDL-C of 53 mg/dL
-
This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls. In this podcast, experts will discuss the following case: A 34-Year-Old Woman with Severe Heterozygous Familial Hypercholesterolemia (HeFH)
-
Tune in to hear our esteemed faculty members, Drs. Morris and Somers, delve into topics such as defining poor sleep, assessing sleep health in patients, and exploring the connection between sleep disorders and cardiometabolic health.
Recorded Saturday, April 20, 2024.
-
A stimulating conversation between our co-chair Pamela Morris, MD and Michelle W. Chestovich, MD, a famous physician life coach on resiliency and physician burn-out.
Recorded Friday, April 19 2024.
https://www.cardiometabolichealth.org/
-
Pamela B. Morris, MD and Erica Spatz, MD, MHS discuss the association of Depression and Poor Mental Health With Cardiovascular Disease, particularly in women.
Recorded April 18, 2024.
www.cardiometabolichealth.org
-
In this conversation with CMHC Senior Planning Committee Member Pam Taub, MD, future leaders Courtney Bess, MD, MS and Aarthi Thakkar, MD, MPH discuss gaps in current fellowship training in cardiometabolic health, how being part of this program and attending CMHC events has helped them in their training, as well as important takeaways they have been able to apply to patient care.
-
Watch Dr. Seth Martin, MD, MHS, discussing the significance of the role of technology and digital health in cardiometabolic risk reduction.
(Recorded October 18, 2023)
-
Watch as CMHC Faculty Pam Taub MD and Ajay Singh MD recapped cardio-renal session at CMHC Annual 2023, where they discussed how cardiologists and nephrologists can work together to tackle cardio-renal diseases, including the latest cardio-renal therapies.
(Recorded October 21, 2023)
-
Watch as CMHC Faculty Christie Ballantyne, MD, Robert Eckel, MD, Erin Michos, MD, Patrick Moriarty, MD, and Paul Ridker, MD, discuss practical pearls about the spectrum of residual ASCVD risk, including:
Inflammation Statin intolerance Elevated triglycerides Lp(a)Recorded October 20, 2023
-
Watch as CMHC faculty Juan Frías, MD and Shivani Agarwal, MD discuss important pearls in the management of type 2 diabetes, including screening for social determinants of health (SDOH), the impact of SDOH on treatment, culturally-sensitive care, as well as the importance of early glycemic control, screening, and GDMT optimization (recorded October 20, 2023).
-
Watch as CMHC faculty Christie Ballantyne, MD, Robert Eckel, MD, Keith Ferdinand, MD, and Anne Peters, MD recap some of the main developments in 2023 across the cardio-renal-metabolic health as discussed at the 18th CMHC Annual meeting, including in obesity, diabetes, dyslipidemia/ASCVD risk, hypertension, and more (recorded October 19, 2023).
-
Watch CMHC co-chairs Christie Ballantyne, MD and Robert Eckel, MD discuss the connections between cardio-renal-metabolic health, and the value of attending the CMCH Annual meeting (recorded October 2023).
-
Vanita Aroda, MD, Associate Professor of Medicine at Harvard Medical School, and Katherine Tuttle, MD, Professor of Medicine at the University of Washington, discuss current disparities in the treatment of women with type 2 diabetes and cardiorenal risk despite the evidence and breadth of available agents. They discuss that women are less likely to receive guideline-directed medical therapy, including both older and newer agents, and less likely to enroll in clinical trials, as well as the need to recognize and address these disparities.
Recorded during 2023 CMHC's Women's Health Masterclass, August 19, 2023.
- Näytä enemmän
